Filed: 2/14/2023ACC: 0001420506-23-000571
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 94 equity positions with a total reported market value of $196.78M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
94
Positions
$196.78M
Total AUM (reported)
48.20M
Total Shares
Allocation by class
COM$138.52M70.4%
COM NEW$25.17M12.8%
CLASS A ORD SHS$8.36M4.2%
SPONSORED ADS$7.45M3.8%
COMMON STOCK$4.65M2.4%
UNIT 08/15/2028$2.04M1.0%
CL A$1.51M0.8%
Portfolio Concentration
Top 3$41.40M21.0%
4–10$46.17M23.5%
11–25$57.88M29.4%
Rest$51.33M26.1%
Top 3 weight
21.0%
Top 10 weight
44.5%
Voting Authority Distribution
Total shares with voting rights: 48.20M
Sole
Full voting authority
48.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole94
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings94
Rows:
ASTRIA THERAPEUTICS INC
SOLEShares1.36M
TypeSH
Market value$20.18M
10.26%
Sole
1.36M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares2.87M
TypeSH
Market value$11.14M
5.66%
Sole
2.87M
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares385K
TypeSH
Market value$10.09M
5.13%
Sole
385K
Shared
0.00
None
0.00
BELLUS HEALTH INC NEW
SOLEShares1.13M
TypeSH
Market value$9.31M
4.73%
Sole
1.13M
Shared
0.00
None
0.00
PEPPERLIME HEALTH ACQUSTN CO
SOLEShares735K
TypeSH
Market value$7.50M
3.81%
Sole
735K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$6.85M
3.48%
Sole
125K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$6.43M
3.27%
Sole
1.02M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares215K
TypeSH
Market value$5.62M
2.85%
Sole
215K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares100K
TypeSH
Market value$5.29M
2.69%
Sole
100K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares140K
TypeSH
Market value$5.17M
2.63%
Sole
140K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares170K
TypeSH
Market value$4.95M
2.52%
Sole
170K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares150K
TypeSH
Market value$4.65M
2.36%
Sole
150K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares160K
TypeSH
Market value$4.35M
2.21%
Sole
160K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares22K
TypeSH
Market value$4.32M
2.20%
Sole
22K
Shared
0.00
None
0.00
XTANT MED HLDGS INC
SOLEShares6.25M
TypeSH
Market value$4.12M
2.10%
Sole
6.25M
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares190K
TypeSH
Market value$4.07M
2.07%
Sole
190K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares90K
TypeSH
Market value$4.05M
2.06%
Sole
90K
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares91K
TypeSH
Market value$3.97M
2.02%
Sole
91K
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares620K
TypeSH
Market value$3.86M
1.96%
Sole
620K
Shared
0.00
None
0.00
OUTLOOK THERAPEUTICS INC
SOLEShares3.33M
TypeSH
Market value$3.59M
1.83%
Sole
3.33M
Shared
0.00
None
0.00
RESMED INC
SOLEShares17K
TypeSH
Market value$3.54M
1.80%
Sole
17K
Shared
0.00
None
0.00
AKOYA BIOSCIENCES INC
SOLEShares330K
TypeSH
Market value$3.16M
1.60%
Sole
330K
Shared
0.00
None
0.00
QUANTERIX CORP
SOLEShares224.80K
TypeSH
Market value$3.11M
1.58%
Sole
224.80K
Shared
0.00
None
0.00
MYRIAD GENETICS INC
SOLEShares212K
TypeSH
Market value$3.08M
1.56%
Sole
212K
Shared
0.00
None
0.00
KORU MEDICAL SYSTEMS INC
SOLEShares855K
TypeSH
Market value$3.05M
1.55%
Sole
855K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASTRIA THERAPEUTICS INCSOLE | COM | 1.36M | SH | $20.18M 10.26% | 1.36M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 2.87M | SH | $11.14M 5.66% | 2.87M | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 385K | SH | $10.09M 5.13% | 385K | 0.00 | 0.00 |
BELLUS HEALTH INC NEWSOLE | COM NEW | 1.13M | SH | $9.31M 4.73% | 1.13M | 0.00 | 0.00 |
PEPPERLIME HEALTH ACQUSTN COSOLE | CLASS A ORD SHS | 735K | SH | $7.50M 3.81% | 735K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 125K | SH | $6.85M 3.48% | 125K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.02M | SH | $6.43M 3.27% | 1.02M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 215K | SH | $5.62M 2.85% | 215K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 100K | SH | $5.29M 2.69% | 100K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 140K | SH | $5.17M 2.63% | 140K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 170K | SH | $4.95M 2.52% | 170K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 150K | SH | $4.65M 2.36% | 150K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 160K | SH | $4.35M 2.21% | 160K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 22K | SH | $4.32M 2.20% | 22K | 0.00 | 0.00 |
XTANT MED HLDGS INCSOLE | COM NEW | 6.25M | SH | $4.12M 2.10% | 6.25M | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 190K | SH | $4.07M 2.07% | 190K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 90K | SH | $4.05M 2.06% | 90K | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 91K | SH | $3.97M 2.02% | 91K | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | COM | 620K | SH | $3.86M 1.96% | 620K | 0.00 | 0.00 |
OUTLOOK THERAPEUTICS INCSOLE | COM NEW | 3.33M | SH | $3.59M 1.83% | 3.33M | 0.00 | 0.00 |
RESMED INCSOLE | COM | 17K | SH | $3.54M 1.80% | 17K | 0.00 | 0.00 |
AKOYA BIOSCIENCES INCSOLE | COM | 330K | SH | $3.16M 1.60% | 330K | 0.00 | 0.00 |
QUANTERIX CORPSOLE | COM | 224.80K | SH | $3.11M 1.58% | 224.80K | 0.00 | 0.00 |
MYRIAD GENETICS INCSOLE | COM | 212K | SH | $3.08M 1.56% | 212K | 0.00 | 0.00 |
KORU MEDICAL SYSTEMS INCSOLE | COM | 855K | SH | $3.05M 1.55% | 855K | 0.00 | 0.00 |
Page 1 of 4